Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/15/2009 | US7588914 Bacterial Bcl-2 domain-containing polypeptides, encoding nucleic acid molecules, and related methods |
09/15/2009 | US7588910 Hemoglobin A1c determination method, enzyme to be used therefor, and production method thereof |
09/15/2009 | US7588901 Modulation of angiogenesis through targeting of arginyl transferase (ATE1) |
09/15/2009 | US7588900 Mammalian sweet and amino acid heterodimeric taste receptors |
09/15/2009 | US7588893 Binding assay using binding agents with tail groups |
09/15/2009 | US7588891 Detection and characterization of nucleic acid sequences and variations in nucleic acid sequences with an immobilized FEN-1 endonuclease on a support that cleaves target nucleic acids in a site-specific manner |
09/15/2009 | US7588890 Non-destructive macromolecules extraction while preserving the morphology and antigenicity of the tissue; extracting biological molecules from thin-section of frozen tissue or paraffin-embedded fixed tissue |
09/15/2009 | US7588888 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
09/15/2009 | US7588887 Stable isotope metabolic labeling for analysis of biopolymers |
09/15/2009 | US7588885 Using amantadine to control translation of infectious enterovirus (EV) or encephalomyocarditis virus (EMCV); viricides |
09/15/2009 | US7588773 vaccines; use for detecting a group B streptococcus serotype III, RDP III-3 strain; drug screen an agent for inhibiting adhesion of a group B streptococcal cell to a host cell |
09/15/2009 | US7588771 anticancer treatment by administering a recombinant vaccina virus of a modified TK thymidine kinase and HA hemagglutinin gene; virus does not accumulate to toxic levels in non-targeted organs |
09/15/2009 | US7588770 Recombinant viruses of the paramyxoviridae family with heterologous envelope glycoproteins |
09/15/2009 | US7588769 Recombinant influenza virus comprising a mutant membrane protein gene, e.g., a mutant integral membrane protein gene such as a mutant type III integral membrane protein gene, which does not encode a functional membrane protein or a functional portion thereof; use in gene therapy |
09/15/2009 | US7588768 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
09/15/2009 | US7588767 Recombinant vaccina virus of a modified TK and HA gene and optionally a modified F3 gene or locus; virus does not accumulate to toxic levels in non-targeted organs |
09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
09/15/2009 | US7588757 Methods of treating Parkinson's disease using recombinant adeno-associated virus virions |
09/15/2009 | US7588756 Administering intracoronally a compatible auxiliary or support and a nucleic acid encoding a polypeptide S100A1 protein; increases the systolic Ca2+ release from the sarcoplasmic reticulum and increases the rate of Ca2+ uptake into the sarcoplasmic reticulum |
09/15/2009 | US7588755 Immunomodulation by administration of a recombinant polypeptide produced by a non-human host transformed by a recombinant DNA molecule ; antiviral and antitumor or anticancer agents |
09/15/2009 | CA2421683C Microparticles for delivery of the heterologous nucleic acids |
09/15/2009 | CA2396058C Methods for isolating and characterizing endogenous mrna-protein (mrnp) complexes |
09/15/2009 | CA2369616C Somatic transgene immunization and related methods |
09/15/2009 | CA2366514C Diagnostic and therapeutic use of antibodies against the urokinase receptor |
09/15/2009 | CA2348828C Genomic and complete cdna sequences of apm1 and biallelic markers thereof |
09/15/2009 | CA2281793C Oligonucleotides that can be used in the amplification and detection of cmv nucleuc acid |
09/15/2009 | CA2204433C Use of neurite localized mrnas for medical diagnosis and therapeutics |
09/15/2009 | CA2195396C Genetic diagnosis of prostate cancer |
09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
09/15/2009 | CA2032158C Multivalent repressor of gene function |
09/14/2009 | CA2640954A1 Hepatitis c virus inhibitors |
09/14/2009 | CA2625811A1 Microrna mediated oncolytic targeting |
09/11/2009 | WO2009111738A2 Single cycle replicating adenovirus vectors |
09/11/2009 | WO2009111706A1 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
09/11/2009 | WO2009111658A2 Compositions and methods for inhibiting expression of eg5 and vegf genes |
09/11/2009 | WO2009111599A2 Plasmodium malariae and plasmodium ovale genes and uses thereof |
09/11/2009 | WO2009111444A1 Modulation of srpx2-mediated angiogenesis |
09/11/2009 | WO2009111375A2 Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas |
09/11/2009 | WO2009111347A1 Purified immunoglobulin fusion proteins and methods of their purification |
09/11/2009 | WO2009111336A2 Methods of purifying plasmid dna |
09/11/2009 | WO2009111263A1 Corn plant event mon87460 and compositions and methods for detection thereof |
09/11/2009 | WO2009110924A1 Antibodies immunoreactive with mutant 5-enolpyruvlshikimate-3-phosphate synthase |
09/11/2009 | WO2009110644A1 Recombinant vaccinia virus having hepatitis c virus gene |
09/11/2009 | WO2009110624A1 γ-GLUTAMULCYSTEINE-PRODUCING YEAST, AND METHOD FOR PRODUCTION OF YEAST EXTRACT |
09/11/2009 | WO2009110606A1 Homologous recombination method, cloning method, and kit |
09/11/2009 | WO2009110473A1 Method of distinguishing inflammatory pathogen causing acute respiratory infection |
09/11/2009 | WO2009110466A1 Genes that increase the production of oil in plants, and method of using the same |
09/11/2009 | WO2009110383A1 Method for screening of therapeutic agent for cancer |
09/11/2009 | WO2009110324A1 Method for regulation of expression of low-density lipoprotein receptor, and enhancer of expression of low-density lipoprotein receptor |
09/11/2009 | WO2009110215A1 Method for induction of ciliated cell differentiation |
09/11/2009 | WO2009110209A1 Mouse with singing mutation |
09/11/2009 | WO2009110113A1 Therapeutic agent for nerve injury and method for treating nerve injury |
09/11/2009 | WO2009109665A1 Pharmaceutical compositions for treatment of microrna related diseases |
09/11/2009 | WO2009109634A1 A pentose sugar fermenting cell |
09/11/2009 | WO2009109633A1 A pentose sugar fermenting cell |
09/11/2009 | WO2009109631A1 A pentose sugar fermenting cell |
09/11/2009 | WO2009109630A1 A pentose sugar fermenting cell |
09/11/2009 | WO2009109615A1 Novel crustacean androgenic gland hormone |
09/11/2009 | WO2009109597A1 Method for producing alpha- santalene |
09/11/2009 | WO2009109572A2 Monovalent phage display of single variable domains |
09/11/2009 | WO2009109500A1 Polypeptides having lipase activity and polynucleotides encoding same |
09/11/2009 | WO2009109368A1 Identification of antigen- or ligand-specific binding proteins |
09/11/2009 | WO2009109360A1 Method of protease production in plants |
09/11/2009 | WO2009109315A2 Modulation of lignin content and composition in feedstock crop biomass |
09/11/2009 | WO2009109146A1 Use of hepatocyte nuclear factor 4α(hnf4α) for the treatment of human malignant solid tumors through induction-differentiation therapy |
09/11/2009 | WO2009109129A1 A new type of consensus interferon and preparation method thereof |
09/11/2009 | WO2009109123A1 An artificial synthesized insecticidal gene and the protein encoded by same and uses thereof |
09/11/2009 | WO2009109102A1 Recombinant microorganism and method for producing l-lysine |
09/11/2009 | WO2009109054A1 Diacylglycerol acyltransferases from flax |
09/11/2009 | WO2009109051A1 Diacyglycerol acyltransferases from flax |
09/11/2009 | WO2009091815A3 Methods for modulating de novo hepatic lipogenesis by modulating xbp-1 activity |
09/11/2009 | WO2009090554A3 Specific aptamers generated for suppression of cell migration and invasion by cancer cells, methods of selection for such aptamers and their usage |
09/11/2009 | WO2009088928A3 Libraries, arrays and their uses for targeted affinity enhancement |
09/11/2009 | WO2009086000A3 Biomarkers for trichogenicity |
09/11/2009 | WO2009079481A3 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma |
09/11/2009 | WO2009077546A3 Lipid metabolism protein and uses thereof ii (phosphate transporter) |
09/11/2009 | WO2009076638A3 Compositions and methods relating to characterization and therapeutic application of pristine stem cells |
09/11/2009 | WO2009076524A3 Polypurine tract modified retroviral vectors |
09/11/2009 | WO2009075798A3 Hydrogenase polypeptide and methods of use |
09/11/2009 | WO2009059305A3 Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation |
09/11/2009 | WO2009011940A3 Microcin h47 plasmid selection system |
09/11/2009 | WO2008082726A3 Real time monitoring of microbial enzymatic pathways |
09/11/2009 | WO2006108658A3 Process for the production of monoclonal antibodies using chimeric vlps |
09/11/2009 | WO2006052795A3 Methods of inhibiting the activity of hsp90 and/or aryl hydrocarbon receptor |
09/11/2009 | WO2006031870A9 Strain independent amplification of pathogens and vaccines thereto |
09/11/2009 | WO2005118866A3 COMPOSITIONS AND METHODS FOR SYNTHESIZING cDNA |
09/11/2009 | CA2749142A1 Cell, method and kit for conducting an assay for neutralizing antibodies |
09/11/2009 | CA2728285A1 Engineered co2 fixing microorganisms producing carbon-based products of interest |
09/11/2009 | CA2717819A1 Diacylglycerol acyltransferases from flax |
09/11/2009 | CA2717818A1 Diacylglycerol acyltransferases from flax |
09/11/2009 | CA2717792A1 Pharmaceutical compositions for treatment of microrna related diseases |
09/11/2009 | CA2717747A1 Compositions and methods for differential regulation of fatty acid unsaturation in membrane lipids and seed oil |
09/11/2009 | CA2717736A1 Modulation of srpx2-mediated angiogenesis |
09/11/2009 | CA2717727A1 Gene that increases production of plant fat-and-oil and method for using the same |
09/11/2009 | CA2717626A1 Recombinant vaccinia virus having hepatitis c virus gene |
09/11/2009 | CA2717618A1 Homologous recombination method, cloning method, and kit |
09/11/2009 | CA2717586A1 Primary alcohol producing organisms |
09/11/2009 | CA2717447A1 Method of protease production in plants |
09/11/2009 | CA2717325A1 Novel crustacean androgenic gland hormone |
09/11/2009 | CA2717244A1 Method of distinguishing inflammatory pathogen causing acute respiratory infection |